First-In-Human, Double-Blind, Placebo-Controlled, Randomized, Dose-Escalation Study of BG00010, a Glial Cell Line-Derived Neurotrophic Factor Family Member, in Subjects with Unilateral Sciatica

OBJECTIVE: To evaluate the safety, tolerability, and pharmacokinetics of single doses of BG00010 (neublastin, artemin, enovin) in subjects with unilateral sciatica. METHODS: This was a single-center, blinded, placebo-controlled, randomized Phase 1 sequential-cohort, dose-escalation study (ClinicalTr...

Descripción completa

Detalles Bibliográficos
Autores principales: Rolan, Paul E., O’Neill, Gilmore, Versage, Eve, Rana, Jitesh, Tang, Yongqiang, Galluppi, Gerald, Aycardi, Ernesto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4427304/
https://www.ncbi.nlm.nih.gov/pubmed/25962165
http://dx.doi.org/10.1371/journal.pone.0125034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4427304/
https://www.ncbi.nlm.nih.gov/pubmed/25962165
http://dx.doi.org/10.1371/journal.pone.0125034

Ejemplares similares